The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones

NCT02180334 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Mosapride citrate
DRUG: Linagliptin
DRUG: Acetaminophen (paracetamol)

Sponsor

Seoul National University Hospital

Collaborators

[object Object]